Cargando…
Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment
BACKGROUND: Metabolomics is the global unbiased analysis of all the small-molecule metabolites within a biological system. Metabolic profiling of different high-resolution computed tomography (HRCT) phenotypes of COPD patients before and after treatment may identify discriminatory metabolites that c...
Autores principales: | Wang, Cheng, Li, Jun-Xiong, Tang, Dang, Zhang, Jian-Qing, Fang, Li-Zhou, Fu, Wei-Ping, Liu, Ling, Dai, Lu-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723127/ https://www.ncbi.nlm.nih.gov/pubmed/29255358 http://dx.doi.org/10.2147/COPD.S152134 |
Ejemplares similares
-
Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006) -
Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021) -
Budesonide/formoterol combination in COPD: a US perspective
por: Sharafkhaneh, Amir, et al.
Publicado: (2010) -
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021) -
The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly
por: Guo, Min, et al.
Publicado: (2022)